Dr G. Vaughan, the author of the article, comments:
Thank you for giving me the opportunity to respond to the letter from Dr Adams about my article. The people and groups involved with drug regulation will appreciate the congratulations given by him.
It is true the evaluation times do refer to the time taken by the Therapeutic Goods Administration (TGA) to carry out its evaluation role. There can be a need, depending on the quality of the application, to seek further information from the applicant company. Naturally the TGA cannot be held responsible for the considerable time taken by companies to respond to some requests.
As indicated above, the need to ask questions is very much related to the quality of the application. If any sponsor believes that the questions are unreasonable, then they can appeal through a Standing Arbitration Committee or the formal appeal processes which were introduced following the Baume report.
The reason why the TGA refers to evaluation time in working days is because the Baume report set standards using this terminology, which was eventually included in the legislation related to evaluation timelines.